155 related articles for article (PubMed ID: 23784455)
21. MicroRNA signature predicts survival in papillary thyroid carcinoma.
Chengfeng X; Gengming C; Junjia Z; Yunxia L
J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
[TBL] [Abstract][Full Text] [Related]
22. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
23. [The role of MicroRNAs in the pathophysiology of neuroblastoma and their possible use in diagnosis, prognosis and therapy].
Vinklárek J; Novák J; Bienertová-Vašků J; Stěrba J; Slabý O
Klin Onkol; 2014; 27(5):331-9. PubMed ID: 25312710
[TBL] [Abstract][Full Text] [Related]
24. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
[TBL] [Abstract][Full Text] [Related]
25. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
[TBL] [Abstract][Full Text] [Related]
27. Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma.
Scaruffi P; Stigliani S; Moretti S; Coco S; De Vecchi C; Valdora F; Garaventa A; Bonassi S; Tonini GP
BMC Cancer; 2009 Dec; 9():441. PubMed ID: 20003513
[TBL] [Abstract][Full Text] [Related]
28. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
30. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
[TBL] [Abstract][Full Text] [Related]
31. Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients.
Russo R; Cimmino F; Pezone L; Manna F; Avitabile M; Langella C; Koster J; Casale F; Raia M; Viola G; Fischer M; Iolascon A; Capasso M
Carcinogenesis; 2017 Oct; 38(10):1011-1020. PubMed ID: 28968651
[TBL] [Abstract][Full Text] [Related]
32. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM
Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD.
Samaraweera L; Spengler BA; Ross RA
Oncol Rep; 2017 Jul; 38(1):545-550. PubMed ID: 28560387
[TBL] [Abstract][Full Text] [Related]
34. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma.
Jin W; Zhang Y; Liu Z; Che Z; Gao M; Peng H
J Cell Physiol; 2021 Jan; 236(1):294-308. PubMed ID: 32510620
[TBL] [Abstract][Full Text] [Related]
35. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.
Zhang Y; Roth JA; Yu H; Ye Y; Xie K; Zhao H; Chang DW; Huang M; Li H; Qu J; Wu X
Carcinogenesis; 2019 Jul; 40(5):643-650. PubMed ID: 30428030
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
Meng X; Fang E; Zhao X; Feng J
Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
Buckley PG; Alcock L; Bryan K; Bray I; Schulte JH; Schramm A; Eggert A; Mestdagh P; De Preter K; Vandesompele J; Speleman F; Stallings RL
Clin Cancer Res; 2010 Jun; 16(11):2971-8. PubMed ID: 20406844
[TBL] [Abstract][Full Text] [Related]
39. Identification of microRNAs as potential prognostic markers in ependymoma.
Costa FF; Bischof JM; Vanin EF; Lulla RR; Wang M; Sredni ST; Rajaram V; Bonaldo Mde F; Wang D; Goldman S; Tomita T; Soares MB
PLoS One; 2011; 6(10):e25114. PubMed ID: 22053178
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
